Invitae Corporation
Invitae Corporation (NVTA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NVTA · as of Jun 9, 2026
Key Statistics
Explore Invitae Corporation Data
nvta stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 26.7%
The NVTA analyst consensus is Hold, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $9.75, representing +51215.79% upside from the current price of $0.02.
Competitors & Peers
nvta competitorsNVTA
FRTX
GBNH
LMDX
NSTG
NUVOStock Performance
Full HistoryAbout Invitae Corporation
Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United Stat…
what is invitae corporation · nvta stock overview · invitae corporation company profile · who is invitae corporation ceo · nvta NYSE · invitae corporation headquarters · invitae corporation business segments
About Stock Overview & Key Data
Invitae Corporation (NVTA) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NYSE since Feb 12, 2015. As of the latest trading session, NVTA stock price is $0.02, with a market capitalization of $5.4M. The stock has returned -98.64% over the past 12 months and -96.90% year-to-date.
According to 15 Wall Street analysts, the consensus rating for Invitae Corporation stock is Hold, with an average 12-month price target of $9.75. In fiscal year 2022, Invitae Corporation reported revenue of $516.3M and net income of -$3.1B. For detailed data — including Invitae Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Invitae Corporation (NVTA) stock price is $0.02. The stock is traded on NYSE under the ticker symbol NVTA. The 52-week range is $0.01 – $2.34.